Loading…
Loading…
EQUITY / NASDAQ · XNCM
Cardiol Therapeutics Inc. Class A Common Shares
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →01/01/2025 – 12/31/2025 · CAD · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗1.4 USD · -0.7092%
Observed: Oct 2, 2026, 11:19 PM · TickerLayer indicative price; may be delayed
Powered by TickerLayer
10/02/2026 · 1.41 USD · Volume 3,591,435
21 actual observations · Latest bar: 2026-10-02 · Market data is indicative; provider terms apply.
4 available financial reports
Research reports →SEC FINANCIAL REPORTS
01/01/2025 – 12/31/2025 · Units
| Metric | 2025 / Year end | 2024 / Year end | Change |
|---|---|---|---|
| Operating profit | -34,316,296 CAD | -40,276,651 CAD | — |
| Net income | -33,818,874 CAD | -36,677,299 CAD | — |
| Operating cash flow | -23,854,650 CAD | -25,060,867 CAD | — |
| Cash and cash equivalents | 21,416,684 CAD | 30,580,029 CAD | -29.97% |
| Total liabilities | 5,742,215 CAD | 7,135,268 CAD | -19.52% |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2025 / Year end01/01/2025 – 12/31/2025ConsolidatedUnits · CAD | 2024 / Year end01/01/2024 – 12/31/2024ConsolidatedUnits · CAD | 2023 / Year end12/31/2023 – 12/31/2023ConsolidatedUnits · CAD | 2023 / Year end01/01/2023 – 12/31/2023ConsolidatedUnits · CAD |
|---|---|---|---|---|
| Cash and cash equivalentsBalance sheet | 21,416,684 CAD | 30,580,029 CAD | 34,931,778 CAD | 34,931,778 CAD |
| Financing cash flowCash flow statement | 15,539,830 CAD | 18,840,337 CAD | — | -55,376 CAD |
| Investing cash flowCash flow statement | -24,484 CAD | -21,290 CAD | — | -64,312 CAD |
| Net incomeIncome statement | -33,818,874 CAD | -36,677,299 CAD | — | -28,128,292 CAD |
| Operating cash flowCash flow statement | -23,854,650 CAD | -25,060,867 CAD | — | -25,180,441 CAD |
| Operating profitIncome statement | -34,316,296 CAD | -40,276,651 CAD | — | -29,785,504 CAD |
| Total assetsBalance sheet | 23,619,933 CAD | 31,863,751 CAD | — | 36,700,508 CAD |
| Total equityBalance sheet | 17,877,718 CAD | 24,728,483 CAD | 28,246,507 CAD | 28,246,507 CAD |
| Total liabilitiesBalance sheet | 5,742,215 CAD | 7,135,268 CAD | — | 8,454,001 CAD |
| Report source | Open report ↗ Published: 03/31/2026 | Open report ↗ Published: 03/31/2026 | Open report ↗ Published: 03/31/2026 | Open report ↗ Published: 03/31/2025 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.